July 31, 2006
Cyclin D1, a gene that promotes the development of breast cancer, is providing clues to how breast cancer spreads, or metastasizes, in the body. By getting a better understanding of the complicated routes by which cancer cells move about, researchers at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia are finding new potential targets for drugs.
July 28, 2006
Taking advantage of a 12-year history of providing the most innovative treatment for patients with brain tumors, physicians in three departments of the Kimmel Cancer Center at Thomas Jefferson University and Thomas Jefferson University Hospital have joined together to expand the service.
July 23, 2006
Gleevec, the wildly successful poster-child of a new generation of cancer drugs aimed at specific targets in the cancer cell, can be dangerous to the heart. Not only that, but other similarly based drugs – called tyrosine kinase inhibitors – could lead to heart problems as well, say researchers at the Center for Translational Medicine at Jefferson Medical College in Philadelphia.
July 18, 2006
Program to Hold Open House July 26 from 4:30 p.m. to 7 p.m.
July 17, 2006
Drugs that block the activity of an enzyme might hold a key to treating chronic and severe disorders such as certain forms of constipation, hemorrhoids, anal fissures, Hirschsprung’s disease and other similar gastrointestinal problems.
July 15, 2006
By demonstrating that a protein – a growth factor called proepithelin – plays a crucial role in the spread of bladder cancer, scientists at Jefferson Medical College and Jefferson’s Kimmel Cancer Center may have identified a potential target for drugs.
July 14, 2006
When virologist Hilary Koprowski, M.D., reported last month in the Proceedings of the National Academy of Sciences how he and colleagues used tobacco plants to produce cancer-fighting monoclonal antibodies that recognize and hunt down breast and colorectal cancer cells, the work represented another step toward a goal he has been pursuing for the last decade.
July 14, 2006
Wills Eye Hospital of Philadelphia will transfer responsibility for its inpatient and ophthalmology residency programs to its longstanding partners, Thomas Jefferson University and Thomas Jefferson University Hospital, effective July 1, 2006.
July 10, 2006
Thomas Jefferson University Hospital has been ranked as the top hospital in Philadelphia for orthopaedics and rehabilitation medicine by U.S.News & World Report in their 2006 Best Hospitals survey.
July 07, 2006
Money to be used to study obesity in African Americans
July 06, 2006
A Thomas Jefferson University team has found that a personalized program of occupational and physical therapy – plus modifications in the home – can go a long way to help elderly individuals continue to live independently and also live longer.